Skip to main content
Loading page, please wait…
HomeCurrent AffairsEditorialsGovt SchemesLearning ResourcesUPSC SyllabusPricingAboutUPSC AI ToolsUPSC AI ToolAI for UPSCUPSC ChatGPT

© 2026 Vaidra. All rights reserved.

PrivacyTerms
Vaidra Logo
Vaidra

Top 7 items + smart groups

UPSC GPT
New
Mains Evaluator
Test Generator
Geography Lab
New
Current Affairs
Daily Solutions
Daily Puzzle

Version 2.0.0 • Built with ❤️ for UPSC aspirants

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Rising MDR & XDR Typhoid in India: Lancet 2023 Study Highlights AMR Challenge

A 2023 Lancet study highlights that India continues to face a high burden of typhoid fever, now compounded by rising multidrug‑ and extensively drug‑resistant strains of Salmonella typhi . The spread of antimicrobial resistance threatens existing treatment protocols, underscoring the need for stronger sanitation, surve…
Overview Typhoid fever remains a major typhoid fever in India. A 2023 study titled ‘Burden of typhoid fever and antimicrobial resistance in India’ published in The Lancet reports a persistently high disease burden and a worrying rise in drug‑resistant strains. Key Developments India accounts for a substantial proportion of global typhoid cases, driven by poor sanitation and limited access to safe drinking water. The study documents an increase in MDR and XDR typhoid isolates across several Indian states. Conventional antibiotics such as ampicillin, chloramphenicol and co‑trimoxazole show reduced efficacy, prompting a shift to newer, costlier drugs. Important Facts The pathogen responsible for the disease is Salmonella typhi . The emergence of AMR has rendered many first‑line drugs ineffective, increasing treatment costs and morbidity. While exact incidence figures were not provided in the brief excerpt, the study emphasizes that the burden is “high” and that resistant strains are spreading beyond traditionally affected pockets. UPSC Relevance Understanding the typhoid‑AMR nexus is vital for multiple UPSC papers. In GS1 (Society & Health) , candidates must discuss communicable disease control, sanitation, and the impact of antimicrobial resistance on public health. In GS3 (Economy) , the rising cost of newer antibiotics and the strain on the healthcare budget illustrate the economic implications of AMR. The issue also touches on GS4 (Ethics) when evaluating equitable access to effective treatment for vulnerable populations. Way Forward Strengthen water‑sanitation‑hygiene (WASH) infrastructure to curb transmission. Implement robust surveillance for MDR and XDR typhoid strains, integrating data into the National Centre for Disease Control (NCDC) framework. Promote rational antibiotic use through stewardship programmes in both public and private health sectors. Accelerate research on affordable, next‑generation typhoid vaccines and explore combination therapies. Facilitate inter‑sectoral coordination between health, finance, and urban development ministries to address the root causes of contamination. Addressing the AMR challenge in typhoid will require a blend of preventive public‑health measures, policy‑driven antibiotic regulation, and sustained investment in research—areas that frequently appear in UPSC examinations.
Loading article...

Quick Reference

Key Insight

Rising MDR/XDR typhoid strains threaten India's health security and budget.

Key Facts

  1. The Lancet 2023 study reported a persistently high burden of typhoid fever in India, accounting for a large share of global cases.
  2. MDR (resistance to ampicillin, chloramphenicol and co‑trimoxazole) and XDR (resistance to almost all available antibiotics) typhoid isolates are increasing across several Indian states.
  3. First‑line drugs are losing efficacy, prompting a shift to newer, costlier antibiotics such as ceftriaxone and azithromycin.
  4. Antimicrobial resistance (AMR) raises treatment costs, morbidity and strains the public‑health budget.
  5. The study urges robust surveillance through the National Centre for Disease Control (NCDC) and stronger WASH infrastructure.
  6. Rational antibiotic use and stewardship programmes are recommended for both public and private health sectors.
  7. Accelerated research on affordable next‑generation typhoid vaccines is highlighted as a long‑term solution.

Background

Typhoid fever, a water‑borne disease, remains a major public‑health challenge in India. The surge in MDR and XDR strains underscores the AMR crisis, linking health outcomes with sanitation, fiscal pressures on the health system and the need for inter‑sectoral governance.

UPSC Syllabus

  • Essay — Youth, Health and Welfare

Mains Angle

GS1 (Health) – Discuss the implications of rising MDR/XDR typhoid for public health policy, budgeting and antimicrobial stewardship, and suggest integrated measures to curb the AMR threat.

Explore:Current Affairs·Editorial Analysis·Govt Schemes·Study Materials·Previous Year Questions·UPSC GPT
  1. Home
  2. Prepare
  3. Current Affairs
  4. Society
  5. Education & Health Initiatives
  6. Rising MDR & XDR Typhoid in India: Lancet 2023 Study Highlights AMR Challenge
GS178% Exam RelevanceEducation & Health Initiatives
Prelims
84%
Mains
74%
Login to bookmark articles
Login to mark articles as complete

Overview

Full Article

Overview

Typhoid fever remains a major typhoid fever in India. A 2023 study titled ‘Burden of typhoid fever and antimicrobial resistance in India’ published in The Lancet reports a persistently high disease burden and a worrying rise in drug‑resistant strains.

Key Developments

  • India accounts for a substantial proportion of global typhoid cases, driven by poor sanitation and limited access to safe drinking water.
  • The study documents an increase in MDR and XDR typhoid isolates across several Indian states.
  • Conventional antibiotics such as ampicillin, chloramphenicol and co‑trimoxazole show reduced efficacy, prompting a shift to newer, costlier drugs.

Important Facts

The pathogen responsible for the disease is Salmonella typhi. The emergence of AMR has rendered many first‑line drugs ineffective, increasing treatment costs and morbidity. While exact incidence figures were not provided in the brief excerpt, the study emphasizes that the burden is “high” and that resistant strains are spreading beyond traditionally affected pockets.

Exam Relevance

Understanding the typhoid‑AMR nexus is vital for multiple UPSC papers. In GS1 (Society & Health), candidates must discuss communicable disease control, sanitation, and the impact of antimicrobial resistance on public health. In GS3 (Economy), the rising cost of newer antibiotics and the strain on the healthcare budget illustrate the economic implications of AMR. The issue also touches on GS4 (Ethics) when evaluating equitable access to effective treatment for vulnerable populations.

Way Forward

  • Strengthen water‑sanitation‑hygiene (WASH) infrastructure to curb transmission.
  • Implement robust surveillance for MDR and XDR typhoid strains, integrating data into the National Centre for Disease Control (NCDC) framework.
  • Promote rational antibiotic use through stewardship programmes in both public and private health sectors.
  • Accelerate research on affordable, next‑generation typhoid vaccines and explore combination therapies.
  • Facilitate inter‑sectoral coordination between health, finance, and urban development ministries to address the root causes of contamination.

Addressing the AMR challenge in typhoid will require a blend of preventive public‑health measures, policy‑driven antibiotic regulation, and sustained investment in research—areas that frequently appear in UPSC examinations.

Read Original on hindu

Rising MDR/XDR typhoid strains threaten India's health security and budget.

Key Facts

  1. The Lancet 2023 study reported a persistently high burden of typhoid fever in India, accounting for a large share of global cases.
  2. MDR (resistance to ampicillin, chloramphenicol and co‑trimoxazole) and XDR (resistance to almost all available antibiotics) typhoid isolates are increasing across several Indian states.
  3. First‑line drugs are losing efficacy, prompting a shift to newer, costlier antibiotics such as ceftriaxone and azithromycin.
  4. Antimicrobial resistance (AMR) raises treatment costs, morbidity and strains the public‑health budget.
  5. The study urges robust surveillance through the National Centre for Disease Control (NCDC) and stronger WASH infrastructure.
  6. Rational antibiotic use and stewardship programmes are recommended for both public and private health sectors.
  7. Accelerated research on affordable next‑generation typhoid vaccines is highlighted as a long‑term solution.

Background & Context

Typhoid fever, a water‑borne disease, remains a major public‑health challenge in India. The surge in MDR and XDR strains underscores the AMR crisis, linking health outcomes with sanitation, fiscal pressures on the health system and the need for inter‑sectoral governance.

UPSC Syllabus Connections

Essay•Youth, Health and Welfare

Mains Answer Angle

GS1 (Health) – Discuss the implications of rising MDR/XDR typhoid for public health policy, budgeting and antimicrobial stewardship, and suggest integrated measures to curb the AMR threat.

Analysis

Related PYQs

No related PYQs linked to this article yet.

Practice Questions

GS1
Easy
Prelims MCQ

Typhoid treatment and AMR

1 marks
4 keywords
GS1
Medium
Mains Short Answer

AMR mitigation strategies

8 marks
4 keywords
GS1
Hard
Mains Essay

AMR and public health policy

25 marks
9 keywords
Related:Daily•Weekly

Loading related articles...

Loading related articles...

Tip: Click articles above to read more from the same date, or use the back button to see all articles.

Rising MDR & XDR Typhoid in India: Lancet ... | UPSC Current Affairs